| Title |
Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, July 2015
|
| DOI | 10.2147/tcrm.s79135 |
| Pubmed ID | |
| Authors |
Nicholas Moore, Charles Pollack, Paul Butkerait |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 13% |
| United Kingdom | 4 | 10% |
| Canada | 2 | 5% |
| New Zealand | 1 | 3% |
| Venezuela, Bolivarian Republic of | 1 | 3% |
| Argentina | 1 | 3% |
| El Salvador | 1 | 3% |
| Australia | 1 | 3% |
| United States | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 22 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 64% |
| Practitioners (doctors, other healthcare professionals) | 10 | 26% |
| Scientists | 3 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 518 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Brazil | 2 | <1% |
| Australia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 512 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 119 | 23% |
| Student > Master | 68 | 13% |
| Researcher | 30 | 6% |
| Student > Ph. D. Student | 28 | 5% |
| Student > Postgraduate | 26 | 5% |
| Other | 79 | 15% |
| Unknown | 168 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 116 | 22% |
| Pharmacology, Toxicology and Pharmaceutical Science | 89 | 17% |
| Nursing and Health Professions | 38 | 7% |
| Agricultural and Biological Sciences | 21 | 4% |
| Biochemistry, Genetics and Molecular Biology | 21 | 4% |
| Other | 53 | 10% |
| Unknown | 180 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 97. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#443,592
of 25,758,211 outputs
Outputs from Therapeutics and Clinical Risk Management
#17
of 1,324 outputs
Outputs of similar age
#4,649
of 278,334 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 47 outputs
Altmetric has tracked 25,758,211 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,324 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,334 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.